Blake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.
Blake A. Morrison, PharmD
Advertisement
Articles by Blake A. Morrison, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
3
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
4
FDA Approves Oral Nilotinib Tablets for Ph+ CML
5